Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Vickie L. Capps currently holds 8,350 shares of Janux Therapeutics, Inc. (JANX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Vickie L. Capps has been a net seller of JANX stock. They have purchased $736.8K and sold $5.4M worth of shares.
Vickie L. Capps's most recent insider trade was on Aug 14, 2025, when they sold 9,818 shares at $0.00 per share.
Vickie L. Capps serves as Executive at Janux Therapeutics, Inc. (JANX). They have executed 200 insider transactions totaling $6.2M over their tenure at the company.
Vickie L. Capps holds the position of Executive at Janux Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
Vickie L. Capps has shown a selling trading pattern, with $736.8K in total purchases and $5.4M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Vickie L. Capps was on Nov 20, 2007, when they sold $1.7M worth of DJO shares. This transaction involved 33,189 shares at $50.25 per share.
Vickie L. Capps currently owns 8,350 shares of Janux Therapeutics, Inc. (JANX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Vickie L. Capps's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Vickie L. Capps has 200 Form 4 filings on record as an insider at Janux Therapeutics, Inc..
Set alerts for Vickie L. Capps and 40,000+ other insiders.